Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip James

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
European Heart Journal|June 28, 2007
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trialChristian Torp-Pedersen, Ian Caterson, Walmir Coutinho, et al.
Obesity (Silver Spring, Md.)|October 10, 2009
Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in periodIan Caterson, Walmir Coutinho, Nick Finer, et al.
BMJ Open|June 19, 2026
Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery (INSPIRE): study protocol for a multicentre randomised controlled trialLu Wang, Shu Li, Philip James Devereaux, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2025
Biomarkers of insulin resistance and their performance as predictors of treatment response in overweight adultsRobert James Brogan, Olav Rooyackers, Bethan E Phillips, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2015
Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I studyMatthew Quintin Fielding Hatton, Robert Hill, John David Fenwick, et al.
British Journal of Sports Medicine|March 23, 2026
Dose-response interplay between light and moderate-to-vigorous physical activity on all-cause mortality risk: a causal inference analysisMengyun Luo, Philip James Clare, Jakob Tarp, et al.
European Journal of Nutrition|July 30, 2022
Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal womenOrlagh Feehan, Pamela Jane Magee, Laura Kirsty Pourshahidi, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialAldo P Maggioni, Ian Caterson, Walmir Coutinho, et al.
Cell Reports|July 13, 2022
A human adipose tissue cell-type transcriptome atlasMarthe Norreen-Thorsen, Eike Christopher Struck, Sofia Öling, et al.
Human Molecular Genetics|January 10, 2014
Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defectAndrew Dauber, Altan Ercan, Jack Lee, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
European Heart Journal|June 28, 2007
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trialChristian Torp-Pedersen, Ian Caterson, Walmir Coutinho, et al.
Obesity (Silver Spring, Md.)|October 10, 2009
Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in periodIan Caterson, Walmir Coutinho, Nick Finer, et al.
BMJ Open|June 19, 2026
Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery (INSPIRE): study protocol for a multicentre randomised controlled trialLu Wang, Shu Li, Philip James Devereaux, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2025
Biomarkers of insulin resistance and their performance as predictors of treatment response in overweight adultsRobert James Brogan, Olav Rooyackers, Bethan E Phillips, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2015
Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I studyMatthew Quintin Fielding Hatton, Robert Hill, John David Fenwick, et al.
British Journal of Sports Medicine|March 23, 2026
Dose-response interplay between light and moderate-to-vigorous physical activity on all-cause mortality risk: a causal inference analysisMengyun Luo, Philip James Clare, Jakob Tarp, et al.
European Journal of Nutrition|July 30, 2022
Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal womenOrlagh Feehan, Pamela Jane Magee, Laura Kirsty Pourshahidi, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialAldo P Maggioni, Ian Caterson, Walmir Coutinho, et al.
Cell Reports|July 13, 2022
A human adipose tissue cell-type transcriptome atlasMarthe Norreen-Thorsen, Eike Christopher Struck, Sofia Öling, et al.
Human Molecular Genetics|January 10, 2014
Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defectAndrew Dauber, Altan Ercan, Jack Lee, et al.
Pageof 18